Posts by: Marta Figueiredo

Marta Figueiredo

Marta Figueiredo holds a BSc in Biology and a MSc in Evolutionary and Developmental Biology from the University of Lisbon, Portugal. She is currently finishing her PhD in Biomedical Sciences at the University of Lisbon, where she focused her research on the role of several signalling pathways in thymus and parathyroid glands embryonic development.

December 10, 2020December 10, 2020

Early, Sustained Growth Hormone Treatment Linked to Greater Benefits in Real-world Study

News

Growth hormone (GH) therapy initiated at an earlier age and sustained for a longer period results in greater improvements in growth and body composition in children with Prader-Willi syndrome (PWS), ... Read more

November 26, 2020November 26, 2020

Survey Finds COVID-19 Disrupted Care, Well-Being of Rare Disease Patients in Europe

News, syndicated

The first wave of COVID-19 in Europe severely disrupted access to care and raised stress and anxiety in people with rare diseases, negatively affecting their health and well-being, according to ... Read more

November 24, 2020November 24, 2020

Gene Silencing Mechanism Linked to PWS Focus of Early Study

News

The maternal SMCHD1 protein ensures genomic imprinting and the effective silencing of particular genes by protecting them from “gene-activating” proteins in the fertilized egg cell (or oocyte), according to a ... Read more

August 27, 2020August 27, 2020

Single, Wearable Motion Sensor Detects Trunk Instability, Poor Walking Symmetry in Study

News

A single, wearable motion sensor placed on the lower back successfully detected poor trunk stability and walking symmetry in adults with Prader-Willi syndrome (PWS), a study showed. These findings suggest ... Read more

July 23, 2020July 23, 2020

Study Links Structural Changes in Brain to Behavioral Problems in PWS Patients

News

Structural changes in a brain region called the cerebellum are associated with behavioral problems in people with Prader-Willi syndrome (PWS), according to a study in Japan. The findings provided, for ... Read more

June 11, 2020June 11, 2020

DCCR Fails to Reduce Excessive Appetite But Improves Other Measures, Data Show

News

Soleno Therapeutics’ investigational oral therapy diazoxide choline controlled-release (DCCR) failed to significantly lower excessive appetite, but it did improve body composition and behavior in Prader-Willi syndrome (PWS) patients, top-line ... Read more

November 27, 2018

Growth Hormone Therapy Can Delay Early Changes in Body Mass in Prader-Willi Patients

News

Prader-Willi syndrome (PWS) patients have earlier-than-normal changes in body mass — associated with an increased risk of obesity, metabolic syndrome, and type 2 diabetes — which can be delayed with growth ... Read more

March 8, 2018March 8, 2018

Obstructive Sleep Apnea in Young PWS Patients May Be More Frequent Than Thought, Study Contends

News

Obstructive sleep apnea is the most frequent sleep breathing disorder in Prader-Willi syndrome (PWS) pediatric patients, according to an Italian study. The results suggest that sleep disorders may be ... Read more